[HTML][HTML] TP53 Co-Mutation Status Association with Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
X Le, C Molife, MS Leusch, MT Rizzo, PM Peterson… - Cancers, 2022 - mdpi.com
Simple Summary There is conflicting evidence on the impact of TP53 co-mutations on
survival in patients with EGFR-mutated advanced non-small cell lung cancer (aNSCLC) …
survival in patients with EGFR-mutated advanced non-small cell lung cancer (aNSCLC) …
TP53 Co-Mutation Status Association with Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer.
X Le, C Molife, MS Leusch, MT Rizzo, PM Peterson… - Cancers, 2022 - europepmc.org
TP53 co-mutations have shown association with poor prognosis in various solid tumors. For
EGFR-mutated advanced non-small cell lung cancer (aNSCLC), conflicting results exist …
EGFR-mutated advanced non-small cell lung cancer (aNSCLC), conflicting results exist …
[HTML][HTML] TP53 Co-Mutation Status Association with Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
X Le, C Molife, MS Leusch, MT Rizzo, PM Peterson… - Cancers, 2022 - ncbi.nlm.nih.gov
TP53 co-mutations have shown association with poor prognosis in various solid tumors. For
EGFR-mutated advanced non-small cell lung cancer (aNSCLC), conflicting results exist …
EGFR-mutated advanced non-small cell lung cancer (aNSCLC), conflicting results exist …
[PDF][PDF] TP53 Co-Mutation Status Association with Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer. Cancers 2022, 14, 6127
X Le, C Molife, MS Leusch, MT Rizzo, PM Peterson… - 2022 - pdfs.semanticscholar.org
TP53 co-mutations have shown association with poor prognosis in various solid tumors. For
EGFR-mutated advanced non-small cell lung cancer (aNSCLC), conflicting results exist …
EGFR-mutated advanced non-small cell lung cancer (aNSCLC), conflicting results exist …
TP53 Co-Mutation Status Association with Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
X Le, C Molife, MS Leusch, MT Rizzo… - …, 2022 - pubmed.ncbi.nlm.nih.gov
TP53 co-mutations have shown association with poor prognosis in various solid tumors. For
EGFR-mutated advanced non-small cell lung cancer (aNSCLC), conflicting results exist …
EGFR-mutated advanced non-small cell lung cancer (aNSCLC), conflicting results exist …
TP53 Co-Mutation Status Association with Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
X Le, C Molife, MS Leusch, MT Rizzo, PM Peterson… - …, 2022 - search.proquest.com
TP53 co-mutations have shown association with poor prognosis in various solid tumors. For
EGFR-mutated advanced non-small cell lung cancer (aNSCLC), conflicting results exist …
EGFR-mutated advanced non-small cell lung cancer (aNSCLC), conflicting results exist …
TP53 Co-Mutation Status Association with Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer
X Le, C Molife, MS Leusch, MT Rizzo… - …, 2022 - mdanderson.elsevierpure.com
TP53 co-mutations have shown association with poor prognosis in various solid tumors. For
EGFR-mutated advanced non-small cell lung cancer (aNSCLC), conflicting results exist …
EGFR-mutated advanced non-small cell lung cancer (aNSCLC), conflicting results exist …
TP53 Co-Mutation Status Association with Clinical Outcomes in Patients with EGFR-Mutant Non-Small Cell Lung Cancer.
X Le, C Molife, MS Leusch, MT Rizzo… - …, 2022 - search.ebscohost.com
Abstract Simple Summary: There is conflicting evidence on the impact of TP53 co-mutations
on survival in patients with EGFR-mutated advanced non-small cell lung cancer (aNSCLC) …
on survival in patients with EGFR-mutated advanced non-small cell lung cancer (aNSCLC) …